We are very happy to announce that Fermata has partnered with BrainsWay on a new investigational TMS Study! This clinical trial is anticipated to enroll over 100 patients with major depressive disorder (MDD) who will be split into two groups – one receiving a novel accelerated treatment protocol featuring an acute phase?over several treatment days, and the other receiving the FDA-cleared standard-of-care protocol which entails an acute phase?over several weeks. In order to be eligible for the study, participants must: ? Be diagnosed with Major Depressive Disorder ? Be between 22-68 years old ? Have taken 1-4 antidepressants in the current depressive episode Full Inclusion/Exclusion criteria can be found on the clinical trials.gov link at the bottom of this post. The benefit to participants include: ? Receiving deep TMS treatment regardless of whether the participant is randomized into the standard-of-care or acute phase. ?It's free! If you are interested in referring someone for this study please fill out the inquiry form on our website, fermata.health. Owen Muir MD DFAACAP Carlene MacMillan, MD, FCTMSS,DFAACAP Aron Tendler Colleen Hanlon https://lnkd.in/ecfWwt-s
Fermata
心理健康保健
Brooklyn，New York 451 位关注者
We specialize in accelerated TMS and breakthrough mental health treatments. It’s about time to feel well.
关于我们
We provide breakthrough mental health treatment in New York City. We specialize in accelerated TMS including SAINT, eTNS for ADHD, nVNS for anxiety and the Prism neurofeedback system for PTSD. It’s about time to feel well.
- 网站
-
https://www.fermata.health
Fermata的外部链接
- 所属行业
- 心理健康保健
- 规模
- 2-10 人
- 总部
- Brooklyn，New York
- 类型
- 私人持股
- 创立
- 2022
地点
-
主要
获取路线
58 N 9th St
103
US，New York，Brooklyn，11249
Fermata员工
-
Carlene MacMillan, MD, FCTMSS,DFAACAP
Chief Medical Officer at Osmind. Radically Genuine, Relentlessly Curious Psychiatric MedTech Leader, Harvard Trained
-
Kharmalina Tong
Pre-PA Student | Interested in Psychiatry, Dermatology and Primary Care
-
Nogga Schwartz
Patient Care Coordinator and Lead TMS Tech at Fermata
动态
-
We are excited to be offering this treatment for PTSD at our practice! Psychedelics are not the only new promising treatment for PTSD.
In the last weeks, we saw a lot of publications saying that #MDMA, if approved, is going to be the first treatment approved in the last 20 years. This is not the case! Last year, Prism for PTSD, by GrayMatters was cleared by the FDA to treat #PTSD adjunct to standard of care. The patient can continue with their standard of care treatments, all treatments are done at the clinic, but can be administered by non-MD practitioner. All this is based on deep science, and an innovative technology is based on an #amygdala biomarker developed from fusing #fMRI and #EEG. Take a look here for more details:
-
We are proud of Amna M. Aslam, MBA, MSc and Carlene MacMillan, MD for representing Fermata so well at the APA and Horizons meetings!
Chief Medical Officer at Osmind. Radically Genuine, Relentlessly Curious Psychiatric MedTech Leader, Harvard Trained
“In the future, there will be no female leaders. There will just be leaders.”- Sheryl Sandberg. It was wonderful to connect with so many inspiring, dynamic and empathic leaders this past week at the American Psychiatric Association annual meeting and at the Horizons PBC NYC meeting! Shoutouts to Mimi Winsberg, M.D. of Brightside Health, Dr. Jamila Hokanson, M.D, MBA of Yale University, Megan Bowers Patterson of American Psychedelic Practitioners Association (APPA), Jazz Glastra of BrainFutures, Michelle Bernabe, RN, KAT of First Tracks, Valerie Porr of TARA4BPD, Sofia Matta, MD of HomeBase, Pamela Montano Arteaga, Amna M. Aslam, MBA, MSc of Fermata, Christina Brezing, MD of Ellenhorn, Caroline Hostetler, PhD of Compass Pathways, Crystal Goodiel of Rocky Mountain Poison & Drug Safety (RMPDS) and of course the legendary Gabrielle Shapiro in her roles at American Psychiatric Association and American Academy of Child and Adolescent Psychiatry (AACAP)! Keep on running the world, girls! And also thanks to the men pictured who cheer them on, Richard Bermudes, M.D. and Brian Clinton! And of course Grady Hannah and Owen Muir MD DFAACAP of Rapid Acting Mental Health Technology for hosting an outstanding summit in the middle of these conferences to help us all connect with each other!
-
-
-
-
-
+6
-
-
Fermata转发了
NeuroSigma is honored to be part of the 2024 cohort for the largest pediatric digital health accelerator, @KidsX! Over the next 10 weeks, NeuroSigma will have the opportunity to accelerate our growth and work with the leading children’s hospitals and entrepreneurial innovators from the #KidsX network to make pediatric care exceptionally impactful, safe, and convenient for children and families. #kidsx #pediatrics #innovation #startups #accelerators #healthcare #entrepreneurs
-
-
Join our co-founders Carlene MacMillan, MD and Owen Muir MD DFAACAP tonight for this important presentation on how medical devices are transforming the field of psychiatry!
Chief Medical Officer at Osmind. Radically Genuine, Relentlessly Curious Psychiatric MedTech Leader, Harvard Trained
TONIGHT at 7PM ET on Zoom: New York County Psychiatric Society's Technology Committee presents: Medical Devices in Psychiatry: Cleared for Takeoff and Available Now. Brian Stackhouse and I will be co-hosting a presentation featuring Ian A. Cook, MD DLFAPA FCTMSS on NeuroSigma's Monarch eTNS for ADHD, Grady Hannah on NightWare for nightmares and Owen Muir MD DFAACAP on Magnus Medical's SAINT TMS as well as GrayMatters Health Prism system for PTSD. The event is free for American Psychiatric Association NY-based members and $30 for out-of-state members and nonmembers. Thank you to NYCPS platinum sponsor Professional Risk Management Services for sponsoring tonight's presentation! To Register:
Medical Devices in Psychiatry: Cleared for Takeoff & Available Now
nycpsych.memberclicks.net
-
We are delighted to be one of the sponsors for this event happening adjacent to the Clinical TMS Society ‘s Annual Meeting in London and hope to see many of you there. Affordable and equitable access to TMS is a major problem and Foundation for the Advancement of Clinical TMS (FACTMS) is paving the way for more accessible care. We’d also encourage you to consider becoming a monthly supporter of their efforts.
Thank you to Fermata for their George sponsorship of our fundraising event, "An Evening on the Thames". The event, scheduled for June 15, is an exclusive four-hour cruise on the Thames to raise critical funds to expand awareness and create greater access for?#tmstherapy. Join us after the?Clinical TMS Society?annual meeting. Seating is limited!?https://factms.org/795-2/ #philanthropymatters #makeanimpact
-
-
Fermata转发了
Change the course of your depression. ?? Hear our SVP of Strategy,?Owen Muir MD, break down how TMS works for depression. ?? TMS is an FDA-approved, medication-free, non-invasive treatment with higher remission rates than antidepressants and psychotherapy. ?? To learn if TMS is an option for you, book a consultation today. ?? https://lnkd.in/gyq2BbzP https://lnkd.in/gQ3mvTBT
Dr. Owen Muir - Change the Course of Your Depression at Acacia Clinics
https://www.youtube.com/